HAEMONETICS CORPORATION (HAE) Net income 2017–2026
HAEMONETICS CORPORATION (HAE) annual net income history from SEC filings — each fiscal year as reported, with year-over-year change.
$97,308FY2026 · since FY2017: -$26.3M → $97,308
| Fiscal year | Value | YoY |
|---|---|---|
| FY2026 | $97,308 | -42.0% |
| FY2025 | $167,679 | -99.9% |
| FY2024 | $117.6M | +1.9% |
| FY2023 | $115.4M | +166.1% |
| FY2022 | $43.4M | -45.4% |
| FY2021 | $79.5M | +3.8% |
| FY2020 | $76.5M | +39.1% |
| FY2019 | $55.0M | +20.7% |
| FY2018 | $45.6M | +273.5% |
| FY2017 | -$26.3M | — |
Source: SEC XBRL filings · For reference only · Not investment advice